ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 73 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $820,000 | -84.3% | 1,263,899 | -23.9% | 0.00% | -100.0% |
| Q3 2016 | $5,229,000 | +7.3% | 1,659,876 | +5.2% | 0.00% | 0.0% |
| Q2 2016 | $4,875,000 | -12.1% | 1,577,721 | +3.0% | 0.00% | 0.0% |
| Q1 2016 | $5,547,000 | -22.5% | 1,532,457 | -0.6% | 0.00% | -50.0% |
| Q4 2015 | $7,156,000 | +14.4% | 1,542,320 | +50.2% | 0.00% | 0.0% |
| Q3 2015 | $6,255,000 | -22.6% | 1,027,049 | +9.6% | 0.00% | 0.0% |
| Q2 2015 | $8,077,000 | +2994.6% | 936,982 | +1505.5% | 0.00% | – |
| Q1 2015 | $261,000 | +411.8% | 58,359 | +80.0% | 0.00% | – |
| Q4 2014 | $51,000 | +112.5% | 32,423 | +163.5% | 0.00% | – |
| Q3 2014 | $24,000 | – | 12,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
| Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
| Abingworth LLP | 437,994 | $679,000 | 0.19% |
| GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
| BVF INC/IL | 559,624 | $884,000 | 0.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
| Perceptive Advisors | 503,156 | $795,000 | 0.07% |
| Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
| Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |